오늘의 이슈
전체 보도
FDA advisory panel narrowly rejects compounding of one peptide, back another
14건·13개 매체·5개국
진보 성향 36%중도 성향 45%보수 성향 19%
4개 매체5개 매체2개 매체
진영별 관점 대조
같은 사건을 세 진영이 어떻게 다르게 규정하는지 — ONP가 정리한 프레임입니다.
전체 보도14건
FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?
🇺🇸 ABC News (US)진보 성향FDA panel rejects only 1 peptide despite backlash
🇺🇸 The Hill중도 성향F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
🇺🇸 The New York Times진보 성향RFK Jr.’s peptide push narrowly gains backing from FDA advisers despite objections from scientists
🇺🇸 Fortune중도 성향FDA advisory panel narrowly rejects compounding of one peptide, back another
🇺🇸 STAT News중도 성향FDA advisers dismiss safety warnings, back four peptide treatments
🇬🇧 Medical XpressFDA panel considers loosening regulations on certain unapproved peptides
🇺🇸 CBS News진보 성향La nueva batalla de los péptidos: la FDA revisa las sustancias promocionadas en redes sociales mientras sus científicos cuestionan su eficacia
🇦🇷 La Nacion (Argentina)보수 성향FDA panel overrules its own scientists to ease access to unproven peptide injections
🇺🇸 Quartz중도 성향Inside the unconventional FDA panel that could reshape the peptide industry
🇺🇸 Business Insider진보 성향US panel backs trendy peptides despite safety concerns
🇦🇪 Gulf News중도 성향US panel backs trendy peptides despite safety concerns
🇸🇬 The Straits Times World보수 성향FDA committee votes to make peptides more widely available
🇺🇸 Science Magazine NewsWhat to Know About Peptides the FDA Is Considering for Use
🇺🇸 The New York Times진보 성향